| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/24/2013 | CA2770851C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling |
| 09/24/2013 | CA2722028C 5-hydroxypyrimidine-4-carboxamide compound |
| 09/24/2013 | CA2595517C Drug carrier and drug carrier kit for inhibiting fibrosis |
| 09/24/2013 | CA2474277C 2,4-pyrimidinediamine compounds and their uses |
| 09/24/2013 | CA2434760C Differentiated cells suitable for human therapy |
| 09/24/2013 | CA2425669C Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/24/2013 | CA2405557C Albumin fusion proteins |
| 09/24/2013 | CA2318857C Use of heregulin as an epithelial cell growth factor |
| 09/19/2013 | WO2013137433A1 Novel antitumor agent comprising combination of three agents |
| 09/19/2013 | WO2013137396A1 NOVEL INTEGRIN α9β1 LIGAND AND USES THEREOF |
| 09/19/2013 | WO2013137371A1 Novel pyrimidine compound and medicine comprising same |
| 09/19/2013 | WO2013137197A1 Biofilm inhibitor |
| 09/19/2013 | WO2013136871A1 Oversulfated chondroitin composition |
| 09/19/2013 | WO2013112949A3 Treatment of circadian rhythm disorders |
| 09/19/2013 | US20130245226 Antibodies To Non-Functional P2X7 Receptor |
| 09/19/2013 | US20130245128 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/19/2013 | US20130245037 Stabilization of Hypoxia Inducible Factor (HIF) Alpha |
| 09/19/2013 | US20130245034 Inhibitors Of Histone Deacetylase |
| 09/19/2013 | US20130244927 Polynucleotides encoding signal peptide-containing molecules |
| 09/19/2013 | US20130243811 Immunostimulatory oligonucleotides and uses thereof |
| 09/19/2013 | US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 09/19/2013 | US20130243755 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2013 | EP2638038A1 Method of treatment for mental disorders |
| 09/18/2013 | EP2637672A1 Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd). |
| 09/18/2013 | CN1697655B Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 09/18/2013 | CN1578779B Small organic molecule regulators of cell proliferation |
| 09/18/2013 | CN103314106A A modified human U1snRNA molecule, a gene encoding for the modified human U1snRNA molecule, an expression vector including the gene, and the use thereof in gene therapy |
| 09/18/2013 | CN103314102A Galectin 9-secreting cell, production method for same, and application for same |
| 09/18/2013 | CN103314099A Lactic bacterium having an effect of ameliorating metabolic syndrome |
| 09/18/2013 | CN103313970A Novel bicyclic compound or salt thereof |
| 09/18/2013 | CN103313718A Growth hormone secretion promoter |
| 09/18/2013 | CN103313696A Skin whitening agent |
| 09/18/2013 | CN103301308A Summer-heat-relieving granule and preparation method thereof |
| 09/18/2013 | CN103301283A Traditional Chinese medicine preparation for treating hernia |
| 09/18/2013 | CN103301265A Traditional Chinese medicinal oral liquid suitable for relieving summer heat |
| 09/18/2013 | CN103301241A Chinese herbal medicine for treating hirudiniasis of aquatic animals and preparation method thereof |
| 09/18/2013 | CN103300488A Bellyband beneficial to child heath |
| 09/18/2013 | CN102716388B Chinese herbal medicine composition for treating night cramp pain of feet and legs |
| 09/18/2013 | CN102145163B Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesity |
| 09/18/2013 | CN102133430B Inductive agent for regeneration of periodontium tissue of temperature sensitivity and preparation method thereof |
| 09/18/2013 | CN101829120B Composition for treatment of external secretion disorders |
| 09/18/2013 | CN101809008B Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof |
| 09/17/2013 | US8536327 Epothilone derivatives |
| 09/17/2013 | US8536229 Acetylene derivatives having MGluR 5 antagonistic activity |
| 09/17/2013 | US8536184 Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof |
| 09/17/2013 | US8536149 TRPM-2 antisense therapy |
| 09/17/2013 | US8535731 Use of extracts of the Cassia alata plant |
| 09/17/2013 | CA2740471C Morpholinopurine derivatives |
| 09/17/2013 | CA2498644C Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (no) production |
| 09/17/2013 | CA2451738C Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine |
| 09/12/2013 | WO2013133413A1 Mucosa-elevating agent |
| 09/12/2013 | WO2013133367A1 Novel triazine derivative |
| 09/12/2013 | WO2013133326A1 Bone-strengthening agent |
| 09/12/2013 | WO2013133325A1 Tricyclic compound |
| 09/12/2013 | WO2013133221A1 micro-RNA INHIBITOR |
| 09/12/2013 | WO2013133032A1 Dipeptidyl peptidase-iv inhibitor |
| 09/12/2013 | WO2013133031A1 Dipeptidyl peptidase-iv inhibitor |
| 09/12/2013 | WO2013132873A1 Promoter for expression of hyaluronic acid synthase gene |
| 09/12/2013 | WO2013131270A1 Scutellarin hydrate and preparation method and use thereof |
| 09/12/2013 | WO2012098537A8 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells |
| 09/12/2013 | US20130239234 Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain |
| 09/12/2013 | US20130237696 Vascular therapeutics |
| 09/12/2013 | US20130237588 Vascular therapeutics |
| 09/12/2013 | US20130237490 Novel antibacterial compounds, methods of making them, and uses thereof |
| 09/12/2013 | US20130236404 Substances and compositions for enhancing dna repair and methods of use |
| 09/11/2013 | EP2636737A1 Skin and hair color-controlling factor |
| 09/11/2013 | EP2636736A1 Novel anti-dr5 antibody |
| 09/11/2013 | EP2636671A1 Organic amine salt of aminobenzoic acid derivative, and method for producing same |
| 09/11/2013 | EP2636666A1 Trans-2-decenoic acid derivative and medicament containing same |
| 09/11/2013 | EP2636409A1 Combined pharmaceutical composition as antifungal agent |
| 09/11/2013 | CN1665807B Novel physiolgically active substances |
| 09/11/2013 | CN103298788A Pyridine derivative and medicinal agent |
| 09/11/2013 | CN103298468A Ring-fused heterocyclic derivative |
| 09/11/2013 | CN103289980A Protease screening methods and proteases indentified thererby |
| 09/11/2013 | CN103288815A Beta-lactamyl vasopression V1a antagonists |
| 09/11/2013 | CN103288793A Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/11/2013 | CN103285372A Cerebroprotein hydrolysate and injection preparation thereof |
| 09/11/2013 | CN103285346A Traditional Chinese medicine composition for treating pleurisy and preparation method thereof |
| 09/11/2013 | CN103285271A Traditional Chinese medicine for treating internal heat type pleurisy due to yin deficiency |
| 09/11/2013 | CN103285209A Health-are product promoting and improving microcirculation and preparation method thereof |
| 09/11/2013 | CN103285145A Pure traditional Chinese medicine preparation for prompting rapid growth of pigs as well as preparation method and application method thereof |
| 09/11/2013 | CN102688418B Traditional Chinese medicine composition for treating night sweat |
| 09/11/2013 | CN102512585B Traditional Chinese medicine used for treating yin deficiency and fire hyperactivity |
| 09/11/2013 | CN102038963B Method for preparing a stabilised menthol emulsion |
| 09/11/2013 | CN101928288B Small molecule compositions for binding to HSP90 |
| 09/11/2013 | CN101909639B Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 09/11/2013 | CN101836978B Solid preparation containing single crystal form |
| 09/11/2013 | CN101815713B Polycyclic compound |
| 09/10/2013 | US8530505 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/10/2013 | US8530448 Compounds and methods for inhibiting selectin-mediated function |
| 09/10/2013 | US8530407 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8529905 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/10/2013 | US8529882 Peptidomimetic protease inhibitors |
| 09/10/2013 | CA2758894C Novel thyroid hormone .beta. receptor agonist |
| 09/10/2013 | CA2755452C Method of regulating glucose metabolism, and reagents related thereto |
| 09/10/2013 | CA2700690C Process for producing reformatsky reagent in stable form |
| 09/10/2013 | CA2650572C Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 09/10/2013 | CA2614544C Heterocycle-substituted benzimidazole derivative |
| 09/10/2013 | CA2579501C Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |